Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00421239
Status:
COMPLETED
Last Update Posted:
2008-12-09
First Post:
2007-01-08
Brief Title:
Risk Factors of Hypertensive Urgencies
Sponsor:
Russian Cardiology Research and Production Center
Organization:
Russian Cardiology Research and Production Center
Study Overview
Official Title:
Retrospective Study of Hypertensive Urgencies in Patients With Arterial Hypertension
Status:
COMPLETED
Status Verified Date:
2008-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OSADA
Brief Summary:
The purpose of this study is to determine whether frequent hypertensive urgencies increase the risk of cardiovascular events in patients with arterial hypertension
Detailed Description:
The spectrum of disorders associated with arterial hypertension AH encompasses chronic uncomplicated hypertension and the hypertensive crises including hypertensive urgences and emergencies Hypertensive crises accounted for more than 25 of all patient visits to a medical section of an emergency department with hypertensive urgences HU accounting for two-third of these cases Hypertensive crises without prompt treatment are often associated with morbidity and mortality We propose to conduct a population-based case-control study of HU in areas of the Russian Federation We will include about thirty study centers and one data coordinating center and will recruit study participants over a period of one years We plan to conduct in-person interviews with 1500 cases and 1500 controls to elicit information on demographic background and history of exposures We intend to test about 20-25 risk factors of HU thus calculated target number of subject is 3000 pts Were going to get access to hospital lists in each study center From the database well select patients with AH and recruit every third participant who came to hospital orand policlinic Every selected participant will be asked to respond to some questions by phone and be divided into two groups Participants who have HU two weeks before the call will be questioned about level of arterial pressure and treatment during HU Participants with often HU every week or more will be included into first group prevalent cases group A Participants with seldom HU every month or less will be included into second group controls group B Cases and controls will be selected from the same population of AH patients Questionnaire contains information about age gender tobacco use data about HU frequency treatment and its complications antihypertensive and concomitant treatment level of blood pressure regularity of taking antihypertensive drugs associated clinical conditions cerebrovascular disease heart disease renal disease peripheral vascular disease PCI CABG if it be possible we intend to collect information of factors influencing prognosis fasting plasma glucose dyslipidaemia serum creatinine serum uric acid left ventricular hypertrophy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None